Oct 29, 2019 - Incyte (INCY) reports better-than-expected results for the third quarter of 2019, owing to strong Jakafi sales.
Nov 04, 2019 - Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.
Nov 04, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales
Nov 14, 2019 - Eli Lilly (LLY) gets an unfavorable FDA panel vote to expand the label of its type II diabetes medicine Jardiance (2.5 mg) for type I diabetes.
Nov 20, 2019 - Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.
Dec 13, 2019 - This week two deals grab headlines in the pharma space. Merck (MRK) offers to buy ArQule for $2.7 billion while Sanofi (SNY) signs a definitive deal to purchase Synthorx for $2.5 billion
Dec 16, 2019 - Lilly's (LLY) regulatory application seeking approval for cancer drug, Cyramza, in combination with erlotinib for treating EGFR-mutated NSCLC in first-line setting gets positive CHMP opinion for approval in EU.
Dec 18, 2019 - Eli Lilly's (LLY) stock up on Tuesday after it provides an upbeat financial guidance for the next year.
Dec 18, 2019 - Top Stock Reports for Johnson & Johnson, Eli Lilly & PNC Financial
Dec 19, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, PNC Financial, EOG Resources and Archer-Daniels-Midland